The Cardiovascular Market Outlook to 2011

TABLE OF CONTENTS
CHAPTER 1: PATIENT POTENTIAL

• Summary
• Introduction
• Cardiovascular risk factors
  • Hypertension
  • Dyslipidemia
  • Diabetes
• Cardiovascular disease
• Acute thrombotic events
  • Acute coronary syndromes
  • Venous thromboembolism
  • Stroke
• Cardiovascular procedures
  • Percutaneous transluminal coronary angioplasty
  • Coronary artery bypass grafting
  • Insertion of implantable cardioverter defibrillator
  • Heart transplantation

CHAPTER 2: GLOBAL CARDIOVASCULAR MARKET ANALYSIS

• Summary
• Introduction
• Key events in the global cardiovascular market, 2005-6
  • Pfizer discontinues torcetrapib development
  • Genomics and new therapeutic targets
  • New therapeutic targets
  • Use of biomarkers/pharmacogenomics
  • Stem cells
  • Genomics
• Market analysis by country
• Market analysis by therapy area
• Leading brands in the global cardiovascular market
• Anti-hypertensives
  • Introduction
  • Analysis of the leading anti-hypertensives
  • Market analysis by drug class
  • ACE inhibitors
  • Calcium channel blockers
  • Angiotensin receptor blockers
  • Beta blockers
  • Diuretics
  • Other hypertension drugs
  • Anti-hypertensives sales forecasts
• Anti-dyslipidemics
  • Introduction
  • Analysis of the leading anti-dyslipidemics
  • Market analysis by drug class
  • Statins
  • Fibrates
  • Non-statin products
  • Anti-dyslipidemic sales forecasts
• Anti-thrombotics
  • Introduction
  • Analysis of the leading anti-thrombotics
  • Market analysis by drug class
  • Anti-platelets
  • Heparins
  • Vitamin K antagonists
  • Fibrinolytics
  • Anti-thrombotics sales forecasts
• Cardiac therapies
  • Introduction
  • Analysis of the leading cardiac therapies
  • Market analysis by drug class
  • Other cardiac therapies
  • Nitrites and nitrates
  • Anti-arrhythmics
  • Cardiac therapies sales forecast

CHAPTER 3: ANALYSIS OF POTENTIAL FUTURE CARDIOVASCULAR BLOCKBUSTERS

• Summary
• Introduction
• Anti-hypertensives
  • Rasilez
  • Exforge
  • CHF-1521
  • Zanipress
  • Clevelox
  • Cardoxal
• Anti-dyslipidemics
  • KS-01-019
  • Synordia
• Anti-thrombotics
  • BAY-597939
  • Rendix
  • Idraparinux
  • Apixaban
  • SSR-126517
• Cardiac therapies
  • Multaq
  • Stedicor
  • RSD1235
  • Laszarin